DaVita Inc.(DVA)Earnings, Financials & Key Ratios

DVA•NYSE

$193.88

$12.79B mkt cap·20.4× P/E·Price updated May 6, 2026

SectorHealthcare IndustryHealthcare Facilities Sub-IndustrySpecialty chronic care clinics

AboutDaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.Show more

Revenue$13.64B+6.5%
EBITDA$2.73B-3.1%
Net Income$747M-20.2%
EPS (Diluted)9.51-11.4%
Gross Margin27%-17.9%
EBITDA Margin19.98%-9.0%
Operating Margin14.74%-9.7%
Net Margin5.47%-25.1%
ROE45.96%+18.7%
ROIC10.47%-10.4%
Debt/Equity12.99+125.2%
Interest Coverage3.51-17.6%

Analysis→Technical→

DVA Key Insights

DaVita Inc. (DVA) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Excellent 3Y average ROE of 37.5%
✓High quality earnings: Operating CF exceeds net income
✓Trading near 52-week high

✗Weaknesses

✗High debt to equity ratio of 13.0x
✗Expensive at 14.7x book value

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

DVA Price & Volume

DaVita Inc. (DVA) stock price & volume — 10-year historical chart

Loading chart...

DVA Growth Metrics

DaVita Inc. (DVA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-0.1%

5 Years3.39%

3 Years5.53%

TTM6.68%

Profit CAGR

10 Years10.72%

5 Years-0.7%

3 Years10.04%

TTM-9.1%

EPS CAGR

10 Years22.5%

5 Years8.28%

3 Years18.54%

TTM-1.49%

Return on Capital

10 Years11.83%

5 Years12.28%

3 Years13.3%

Last Year14.04%

DVA Recent Earnings

DaVita Inc. (DVA) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 9/12 qtrs (75%)●Beat Revenue 9/12 qtrs (75%)

Q2 2026Latest

May 5, 2026

EPS

$2.87

Est $2.33

+23.2%

Revenue

$3.4B

Est $3.4B

+1.8%

Q1 2026

Feb 2, 2026

EPS

$3.40

Est $3.24

+4.9%

Revenue

$3.6B

Est $3.5B

+3.2%

Q4 2025

Oct 29, 2025

EPS

$2.51

Est $3.17

-20.8%

Revenue

$3.4B

Est $3.4B

-0.2%

Q3 2025

Aug 5, 2025

EPS

$2.95

Est $2.70

+9.3%

Revenue

$3.4B

Est $3.4B

-1.8%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q2 2026Latest	May 5, 2026	$2.87vs $2.33+23.2%	$3.4Bvs $3.4B+1.8%
Q1 2026	Feb 2, 2026	$3.40vs $3.24+4.9%	$3.6Bvs $3.5B+3.2%
Q4 2025	Oct 29, 2025	$2.51vs $3.17-20.8%	$3.4Bvs $3.4B-0.2%
Q3 2025	Aug 5, 2025	$2.95vs $2.70+9.3%	$3.4Bvs $3.4B-1.8%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
FMSFresenius Medical Care AG & Co. KGaADirect Competitor	11.74B	21.01	10.66	1.51%	4.98%	6.74%	0.76
FXNCFirst National CorporationDirect Competitor	248.63M	27.50	14.03	27.11%		9.98%	0.23
UNHUnitedHealth Group IncorporatedDirect Competitor	333.37B	367.28	27.76	11.81%	2.68%	11.54%	0.77
HUMHumana Inc.Direct Competitor	29.57B	246.33	25.03	10.06%	0.82%	6.17%	0.73
CNCCentene CorporationDirect Competitor	27.31B	55.32	-4.06	19.44%	-3.25%	-28.6%	0.94
USPHU.S. Physical Therapy, Inc.Product Competitor	1.12B	73.61	51.84	16.33%	1.52%	1.36%	0.55
AMSFAMERISAFE, Inc.Product Competitor	556.33M	29.60	11.98	2.63%	14.27%	9.68%	0.00
PNTGThe Pennant Group, Inc.Product Competitor	1.13B	32.53	38.73	36.31%	2.96%	8.42%	1.21

Compare DVA vs Peers

DaVita Inc. (DVA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs FMS

Most directly comparable listed peer for DVA.

Scale Benchmark

vs UNH

Larger-name benchmark to compare DVA against a more recognizable public peer.

Peer Set

Compare Top 5

vs FMS, FXNC, UNH, HUM

DVA Income Statement

DaVita Inc. (DVA) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Sales/Revenue	10.88B	11.4B	11.39B	11.55B	11.62B	11.61B	12.14B	12.82B	13.64B	13.84B
Revenue Growth %	-26.24%	4.86%	-0.14%	1.42%	0.59%	-0.08%	4.57%	5.56%	6.46%	6.68%
Cost of Goods Sold	7.64B	8.2B	7.91B	7.99B	7.97B	8.21B	8.32B	8.6B	9.96B	9.53B
COGS % of Revenue	70.24%	71.86%	69.5%	69.16%	68.62%	70.71%	68.53%	67.09%	73%	-
Gross Profit	3.24B▲ 0%	3.21B▼ 0.8%	3.47B▲ 8.2%	3.56B▲ 2.5%	3.65B▲ 2.4%	3.4B▼ 6.7%	3.82B▲ 12.4%	4.22B▲ 10.4%	3.68B▼ 12.6%	4.3B▲ 0%
Gross Margin %	29.76%	28.14%	30.5%	30.84%	31.38%	29.29%	31.47%	32.91%	27%	31.1%
Gross Profit Growth %	-1.2%	-0.84%	8.25%	2.53%	2.37%	-6.75%	12.35%	10.38%	-12.63%	-
Operating Expenses	1.42B	1.68B	1.83B	1.87B	1.85B	2.06B	2.22B	2.13B	1.67B	2.23B
OpEx % of Revenue	13.09%	14.76%	16.07%	16.17%	15.91%	17.75%	18.27%	16.59%	12.27%	-
Selling, General & Admin	1.06B	1.14B	1.1B	1.25B	1.2B	1.36B	1.47B	1.54B	1.67B	1.72B
SG&A % of Revenue	9.78%	9.96%	9.69%	10.8%	10.29%	11.67%	12.14%	12%	12.27%	-
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	359.85M	548.06M	727.37M	619.77M	653.68M	706.08M	743.66M	588.21M	0	3M
Operating Income	1.81B▲ 0%	1.53B▼ 15.8%	1.64B▲ 7.7%	1.69B▲ 3.1%	1.8B▲ 6.1%	1.34B▼ 25.5%	1.6B▲ 19.7%	2.09B▲ 30.4%	2.01B▼ 3.8%	2.08B▲ 0%
Operating Margin %	16.67%	13.38%	14.43%	14.67%	15.47%	11.53%	13.2%	16.31%	14.74%	15.01%
Operating Income Growth %	-10.69%	-15.83%	7.7%	3.12%	6.06%	-25.5%	19.69%	30.43%	-3.82%	-
EBITDA	2.37B	2.12B	2.26B	2.33B	2.48B	2.07B	2.35B	2.81B	2.73B	2.79B
EBITDA Margin %	21.81%	18.56%	19.83%	20.13%	21.33%	17.84%	19.34%	21.96%	19.98%	20.19%
EBITDA Growth %	-6.56%	-10.78%	6.69%	2.95%	6.58%	-16.4%	13.35%	19.85%	-3.14%	1.26%
D&A (Non-Cash Add-back)	559.91M	591.03M	615.15M	630.43M	680.62M	732.6M	745.44M	723.86M	715.35M	716.73M
EBIT	1.83B	1.54B	1.64B	1.62B	1.8B	1.32B	1.58B	2B	1.93B	1.98B
Net Interest Income	-430.63M	-487.44M	-443.82M	-304.11M	-285.25M	-357.02M	-398.55M	-470.47M	-549.67M	-559.75M
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	430.63M	487.44M	443.82M	304.11M	285.25M	357.02M	398.55M	470.47M	549.67M	559.75M
Other Income/Expense	-412.97M	-477.35M	-447.88M	-376.37M	-278.88M	-372.78M	-425.69M	-560.09M	-663.79M	-674.98M
Pretax Income	1.4B▲ 0%	1.05B▼ 25.1%	1.2B▲ 14.0%	1.32B▲ 10.3%	1.52B▲ 15.2%	966.28M▼ 36.4%	1.18B▲ 21.8%	1.53B▲ 30.0%	1.35B▼ 12.0%	1.4B▲ 0%
Pretax Margin %	12.87%	9.19%	10.5%	11.41%	13.07%	8.32%	9.7%	11.94%	9.87%	10.13%
Income Tax	323.86M	258.4M	279.63M	313.93M	306.73M	198.09M	220.12M	279.66M	293.11M	305.19M
Effective Tax Rate %	23.14%	24.65%	23.39%	23.81%	20.2%	20.5%	18.7%	18.27%	21.76%	21.77%
Net Income	663.62M▲ 0%	159.39M▼ 76.0%	810.98M▲ 408.8%	773.64M▼ 4.6%	978.45M▲ 26.5%	560.4M▼ 42.7%	691.53M▲ 23.4%	936.34M▲ 35.4%	746.8M▼ 20.2%	781.42M▲ 0%
Net Margin %	6.1%	1.4%	7.12%	6.7%	8.42%	4.83%	5.7%	7.31%	5.47%	5.65%
Net Income Growth %	-24.58%	-75.98%	408.79%	-4.6%	26.47%	-42.73%	23.4%	35.4%	-20.24%	-9.1%
Net Income (Continuing)	1.08B	790.08M	915.81M	1B	1.21B	768.19M	956.98M	1.25B	1.05B	1.1B
Discontinued Operations	-245.37M	-457.04M	105.48M	-9.65M	0	13.45M	0	0	25M	1000K
Minority Interest	1.21B	1.33B	1.37B	1.51B	1.62B	1.51B	1.69B	1.97B	1.81B	1.8B
EPS (Diluted)	3.47▲ 0%	4.58▲ 32.0%	5.27▲ 15.1%	6.39▲ 21.3%	8.90▲ 39.3%	5.71▼ 35.8%	7.42▲ 29.9%	10.73▲ 44.6%	9.51▼ 11.4%	11.35▲ 0%
EPS Growth %	-19.11%	31.99%	15.07%	21.25%	39.28%	-35.84%	29.95%	44.61%	-11.37%	-1.49%
EPS (Basic)	3.52	4.63	5.29	6.54	9.30	5.88	7.62	11.02	9.72	-
Diluted Shares Outstanding	191.35M	172.36M	153.81M	122.62M	109.95M	95.83M	93.18M	87.27M	88.1M	68.88M
Basic Shares Outstanding	188.63M	170.79M	153.18M	119.8M	105.23M	92.99M	90.79M	84.99M	86.1M	67.39M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

DVA Balance Sheet

DaVita Inc. (DVA) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Total Current Assets	8.74B	8.42B	3.69B	3.15B	3.17B	3.16B	3.14B	3.75B	4.06B	4.06B
Cash & Short-Term Investments	541.06M	325.97M	1.11B	345.06M	484.21M	321.78M	391.67M	846M	782.05M	748.71M
Cash Only	508.23M	323.04M	1.1B	324.96M	461.9M	244.09M	380.06M	794.93M	757.75M	726.4M
Short-Term Investments	43.52M	2.94M	11.57M	20.1M	22.31M	77.69M	11.61M	51.06M	24.3M	22.3M
Accounts Receivable	2.16B	2.4B	2.31B	2.44B	2.41B	2.55B	2.42B	2.56B	2.96B	2.98B
Days Sales Outstanding	72.6	76.71	73.88	77.07	75.73	80.19	72.64	72.85	79.16	78.65
Inventory	181.8M	107.38M	97.95M	111.63M	107.43M	109.12M	143.1M	134.56M	160.63M	141.61M
Days Inventory Outstanding	8.69	4.78	4.52	5.1	4.92	4.85	6.28	5.71	5.89	5.62
Other Current Assets	5.78B	5.48B	106.35M	176.83M	93.06M	173.74M	187.22M	207.84M	156.28M	35.78M
Total Non-Current Assets	10.2B	10.69B	13.62B	13.84B	13.95B	13.77B	13.76B	13.54B	13.42B	13.44B
Property, Plant & Equipment	3.15B	3.39B	6.3B	6.38B	6.3B	5.92B	5.57B	5.33B	5.21B	5.15B
Fixed Asset Turnover	3.45x	3.36x	1.81x	1.81x	1.84x	1.96x	2.18x	2.40x	2.62x	2.61x
Goodwill	6.61B	6.84B	6.79B	6.92B	7.05B	7.08B	7.11B	7.38B	7.55B	7.58B
Intangible Assets	113.83M	118.85M	135.68M	166.59M	177.69M	182.69M	203.22M	197.43M	222.13M	229.02M
Long-Term Investments	283.23M	260.04M	278.5M	289.68M	288.39M	275.44M	593.74M	370.34M	198.22M	838.98M
Other Non-Current Assets	47.29M	71.58M	115.97M	79.5M	136.68M	315.59M	271.25M	261.73M	246.52M	873.7M
Total Assets	18.95B▲ 0%	19.11B▲ 0.9%	17.31B▼ 9.4%	16.99B▼ 1.9%	17.12B▲ 0.8%	16.93B▼ 1.1%	16.89B▼ 0.2%	17.29B▲ 2.3%	17.48B▲ 1.1%	17.5B▲ 0%
Asset Turnover	0.57x	0.60x	0.66x	0.68x	0.68x	0.69x	0.72x	0.74x	0.78x	0.79x
Asset Growth %	1.1%	0.86%	-9.41%	-1.87%	0.78%	-1.13%	-0.2%	2.32%	1.13%	7.46%
Total Current Liabilities	3.04B	4.89B	2.37B	2.48B	2.4B	2.62B	2.64B	2.97B	3.14B	2.87B
Accounts Payable	509.12M	463.27M	403.84M	434.25M	402.05M	479.78M	514.53M	547.2M	696.15M	691.26M
Days Payables Outstanding	24.32	20.63	18.62	19.84	18.41	21.33	22.57	23.23	25.51	25.25
Short-Term Debt	178.21M	1.93B	130.71M	168.54M	179.03M	231.4M	123.3M	270.87M	109.2M	112.65M
Deferred Revenue (Current)	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	2.2B	2.33B	1.3B	1.37B	1.24B	1.35B	1.42B	1.53B	1.09B	836.79M
Current Ratio	2.88x	1.72x	1.56x	1.27x	1.32x	1.20x	1.19x	1.26x	1.29x	1.29x
Quick Ratio	2.82x	1.70x	1.51x	1.23x	1.28x	1.16x	1.13x	1.21x	1.24x	1.24x
Cash Conversion Cycle	56.96	60.86	59.77	62.33	62.24	63.71	56.34	55.33	59.54	59.03
Total Non-Current Liabilities	10.01B	9.19B	11.44B	11.62B	12.35B	12.08B	11.51B	12.22B	13.18B	13.58B
Long-Term Debt	9.16B	8.17B	7.98B	7.92B	8.73B	8.69B	8.27B	9.18B	12.34B	10.51B
Capital Lease Obligations	0	0	2.72B	2.74B	2.67B	2.5B	2.33B	2.21B	2.18B	8.56B
Deferred Tax Liabilities	486.25M	562.54M	577.54M	809.6M	830.95M	782.79M	726.22M	665.36M	756.87M	2.96B
Other Non-Current Liabilities	365.32M	450.67M	160.81M	150.06M	119.16M	105.23M	183.07M	169.59M	-2.09B	-3.77B
Total Liabilities	13.08B	14.08B	13.81B	14.09B	14.75B	14.7B	14.15B	15.19B	16.32B	16.45B
Total Debt	9.34B	10.1B	11.18B	11.19B	11.98B	11.82B	11.12B	12.07B	15.05B	13.22B
Net Debt	8.83B	9.78B	10.07B	10.87B	11.51B	11.58B	10.74B	11.27B	14.29B	12.49B
Debt / Equity	1.58x	2.01x	3.19x	3.86x	5.05x	5.31x	4.05x	5.77x	12.99x	12.99x
Debt / EBITDA	3.93x	4.77x	4.95x	4.81x	4.83x	5.71x	4.73x	4.29x	5.52x	4.73x
Net Debt / EBITDA	3.72x	4.62x	4.46x	4.67x	4.65x	5.59x	4.57x	4.01x	5.24x	5.24x
Interest Coverage	4.25x	3.15x	3.69x	5.33x	6.32x	3.71x	3.95x	4.25x	3.51x	3.54x
Total Equity	5.9B▲ 0%	5.03B▼ 14.7%	3.5B▼ 30.5%	2.9B▼ 17.2%	2.37B▼ 18.2%	2.22B▼ 6.2%	2.74B▲ 23.3%	2.09B▼ 23.8%	1.16B▼ 44.6%	1.05B▲ 0%
Equity Growth %	1.28%	-14.66%	-30.47%	-17.23%	-18.15%	-6.17%	23.31%	-23.77%	-44.61%	-148.57%
Book Value per Share	30.82	29.20	22.75	23.62	21.56	23.22	29.44	23.96	13.15	15.22
Total Shareholders' Equity	4.69B	3.7B	2.13B	1.38B	755.51M	712.33M	1.06B	121.12M	-651.08M	-755.5M
Common Stock	182K	166K	126K	110K	97K	90K	89K	90K	69K	69K
Retained Earnings	3.63B	2.74B	1.43B	852.54M	354.34M	174.49M	598.29M	1.53B	-328.43M	-179.24M
Treasury Stock	0	0	0	0	0	0	0	-1.39B	-199.94M	-489.36M
Accumulated OCI	13.23M	-34.92M	-47.5M	-66.15M	-139.25M	-69.19M	-52.08M	-310.8M	-122.78M	-86.96M
Minority Interest	1.21B	1.33B	1.37B	1.51B	1.62B	1.51B	1.69B	1.97B	1.81B	1.8B

DVA Cash Flow Statement

DaVita Inc. (DVA) cash flow — operating, investing & free cash flow history

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Cash from Operations	1.91B	1.77B	2.07B	1.98B	1.93B	1.56B	2.06B	2.02B	1.89B	1.89B
Operating CF Margin %	17.54%	15.53%	18.2%	17.13%	16.62%	13.48%	16.96%	15.78%	13.83%	-
Operating CF Growth %	-2.85%	-7.12%	16.97%	-4.5%	-2.43%	-18.97%	31.6%	-1.8%	-6.7%	21.4%
Net Income	830.55M	333.04M	1.02B	994.68M	1.21B	781.64M	691.53M	1.25B	1.08B	781.42M
Depreciation & Amortization	777.49M	591.03M	615.15M	630.43M	680.62M	732.6M	745.44M	723.86M	715.35M	530.19M
Stock-Based Compensation	35.09M	73.06M	67.85M	91.46M	102.21M	95.43M	112.38M	102.79M	139.95M	99.96M
Deferred Taxes	-395.22M	273.66M	41.72M	240.85M	60.48M	-75.67M	-39.35M	-57.84M	86.57M	119.45M
Other Non-Cash Items	1.05B	401.94M	239.48M	125.78M	16.45M	30.47M	354.5M	32.31M	129.15M	612.68M
Working Capital Changes	-394.5M	98.9M	86.86M	-104.17M	-140.64M	101K	194.53M	-29.82M	-263.24M	-194.76M
Change in Receivables	-156.31M	-81.18M	-79.96M	-21.09M	-138.14M	-148.39M	172.36M	-29.77M	-210.63M	-85.11M
Change in Inventory	-18.63M	73.5M	10.16M	-12.35M	5.72M	-757K	-32.13M	17.94M	-19.95M	15.1M
Change in Payables	26.88M	-35.96M	-84.54M	37.2M	-30.32M	87.48M	26.89M	1.7M	128.3M	58.33M
Cash from Investing	-1.37B	-1.01B	3B	-825.37M	-784.73M	-630.35M	-771.8M	-771.43M	-654.95M	-631.9M
Capital Expenditures	-905.25M	-987.14M	-766.55M	-674.54M	-641.47M	-603.43M	-567.99M	-555.44M	-575.86M	-534.62M
CapEx % of Revenue	8.32%	8.66%	6.73%	5.84%	5.52%	5.2%	4.68%	4.33%	4.22%	-
Acquisitions	-808.7M	-202.33M	-110.23M	-204.35M	-200.97M	-89.19M	-26.39M	-251.27M	0	-34.13M
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	92.44M	153.85M	3.88B	53.28M	63.66M	120.76M	35.52M	32.54M	-36.34M	-48.32M
Cash from Financing	-766.26M	-625.35M	-4.7B	-1.85B	-1.08B	-1.12B	-1.17B	-816.94M	-1.37B	-1.21B
Debt Issued (Net)	154.85M	699.8M	-2.08B	-169.38M	754.25M	-11.28M	-552.62M	1.11B	769.62M	1.65B
Equity Issued (Net)	-802.95M	-1.15B	-2.37B	-1.46B	-1.6B	-783.65M	-255.32M	-1.37B	-1.77B	-1.62B
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-802.95M	-1.16B	-2.38B	-1.46B	-1.6B	-802.23M	-272.22M	-1.39B	-1.79B	-1.65B
Other Financing	-118.16M	-177.22M	-243.82M	-217.98M	-238.59M	-326.2M	-362.56M	-560.55M	-374.69M	-1.24B
Net Change in Cash	-166.54M▲ 0%	-103.5M▲ 37.9%	793.3M▲ 866.5%	-706.93M▼ 189.1%	53.17M▲ 107.5%	-215.97M▼ 506.2%	125.64M▲ 158.2%	415.19M▲ 230.4%	-122.08M▼ 129.4%	201.83M▲ 0%
Free Cash Flow	1B▲ 0%	784.5M▼ 21.7%	1.31B▲ 66.5%	1.3B▼ 0.1%	1.29B▼ 1.2%	961.14M▼ 25.5%	1.49B▲ 55.1%	1.47B▼ 1.6%	1.31B▼ 10.6%	1.49B▲ 0%
FCF Margin %	9.21%	6.88%	11.47%	11.29%	11.1%	8.28%	12.28%	11.44%	9.61%	10.79%
FCF Growth %	-11.65%	-21.72%	66.45%	-0.1%	-1.16%	-25.46%	55.13%	-1.64%	-10.63%	-15.15%
FCF per Share	5.24	4.55	8.49	10.64	11.73	10.03	16.00	16.80	14.88	14.88
FCF Conversion (FCF/Net Income)	2.87x	11.11x	2.56x	2.56x	1.97x	2.79x	2.98x	2.16x	2.53x	1.91x
Interest Paid	424.55M	488.97M	473.18M	326.17M	279M	351M	387.66M	423.36M	0	0
Taxes Paid	387.16M	92.53M	157.98M	154.85M	154.85M	344.43M	268.09M	387.94M	0	0

DVA Key Ratios

DaVita Inc. (DVA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTM
Return on Equity (ROE)	11.32%	2.92%	19.01%	24.19%	37.15%	24.39%	27.84%	38.73%	45.96%	59.11%
Return on Invested Capital (ROIC)	9.38%	7.75%	8.68%	9.3%	9.75%	7.25%	8.81%	11.68%	10.47%	10.47%
Gross Margin	29.76%	28.14%	30.5%	30.84%	31.38%	29.29%	31.47%	32.91%	27%	31.1%
Net Margin	6.1%	1.4%	7.12%	6.7%	8.42%	4.83%	5.7%	7.31%	5.47%	5.65%
Debt / Equity	1.58x	2.01x	3.19x	3.86x	5.05x	5.31x	4.05x	5.77x	12.99x	12.99x
Interest Coverage	4.25x	3.15x	3.69x	5.33x	6.32x	3.71x	3.95x	4.25x	3.51x	3.54x
FCF Conversion	2.87x	11.11x	2.56x	2.56x	1.97x	2.79x	2.98x	2.16x	2.53x	1.91x
Revenue Growth	-26.24%	4.86%	-0.14%	1.42%	0.59%	-0.08%	4.57%	5.56%	6.46%	6.68%

DVA SEC Filings & Documents

DaVita Inc. (DVA) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

May 5, 2026·SEC

Material company update

Feb 2, 2026·SEC

Material company update

Nov 25, 2025·SEC

10-K Annual Reports

FY 2026

Feb 11, 2026·SEC

FY 2025

Feb 13, 2025·SEC

FY 2024

Feb 14, 2024·SEC

10-Q Quarterly Reports

FY 2026

May 5, 2026·SEC

FY 2025

Oct 29, 2025·SEC

FY 2025

Aug 5, 2025·SEC

DVA Frequently Asked Questions

DaVita Inc. (DVA) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

DaVita Inc. (DVA) reported $13.84B in revenue for fiscal year 2025. This represents a 4970% increase from $272.9M in 1996.

DaVita Inc. (DVA) grew revenue by 6.5% over the past year. This is steady growth.

Yes, DaVita Inc. (DVA) is profitable, generating $781.4M in net income for fiscal year 2025 (5.5% net margin).

Dividend & Returns

DaVita Inc. (DVA) has a return on equity (ROE) of 46.0%. This is excellent, indicating efficient use of shareholder capital.

DaVita Inc. (DVA) generated $1.49B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More DVA

DaVita Inc. (DVA) financial analysis — history, returns, DCA and operating performance tools

Full DVA Stock Analysis

Analyst verdict, bull/bear case, risk factors and peer comparison

→

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

DaVita Inc.(DVA)Earnings, Financials & Key Ratios

DVA Key Insights

✓Strengths

✗Weaknesses

DVA Price & Volume

DVA Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

DVA Recent Earnings

DVA Peer Comparison

Compare DVA vs Peers

vs FMS

vs UNH

Compare Top 5

DVA Income Statement

DVA Balance Sheet

DVA Cash Flow Statement

DVA Key Ratios

DVA SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

DVA Frequently Asked Questions

Explore More DVA

Full DVA Stock Analysis

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation